| アブストラクト | Advances in genetics hold promise for integrating genomics into vaccine safety research. Given the rarity of many vaccine adverse effects, and the challenges in finding sufficient numbers of patients to study, consideration should be given to employing the Vaccine Adverse Event Reporting System (VAERS) for genetic studies of vaccine adverse events. VAERS could be used to build a repository of biospecimens allowing for the systematic evaluation of vaccine adverse events. If successful, such research would enable the identification of specific subgroups of people at particularly increased risk for adverse events. |
|---|
| ジャーナル名 | Vaccine |
|---|
| 投稿日 | 2011/12/20 |
|---|
| 投稿者 | Davis, Robert Lowell |
|---|
| 組織名 | Center for Health Research Southeast, Kaiser Permanente Georgia, Atlanta, GA;30305, United States. Robert.L.Davis@kp.org |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/22178101/ |
|---|
